As of 2025-07-14, the Relative Valuation of Edwards Lifesciences Corp (EW) is 170.59 USD. This relative valuation is based on P/E multiples. With the latest stock price at 78.05 USD, the upside of Edwards Lifesciences Corp based on Relative Valuation is 118.6%.
The range of the Relative Valuation is 74.48 - 300.33 USD.
| Range | Selected | |
| Trailing P/E multiples | 32.0x - 42.1x | 35.4x |
| Forward P/E multiples | 32.9x - 44.5x | 39.2x |
| Fair Price | 74.48 - 300.33 | 170.59 |
| Upside | -4.6% - 284.8% | 118.6% |
| Date | P/E |
| 2025-07-11 | 10.95 |
| 2025-07-10 | 11.06 |
| 2025-07-09 | 10.83 |
| 2025-07-08 | 10.72 |
| 2025-07-07 | 10.76 |
| 2025-07-03 | 10.77 |
| 2025-07-02 | 10.81 |
| 2025-07-01 | 10.83 |
| 2025-06-30 | 10.97 |
| 2025-06-27 | 10.97 |
| 2025-06-26 | 10.83 |
| 2025-06-25 | 10.80 |
| 2025-06-24 | 10.64 |
| 2025-06-23 | 10.57 |
| 2025-06-20 | 10.36 |
| 2025-06-18 | 10.38 |
| 2025-06-17 | 10.28 |
| 2025-06-16 | 10.50 |
| 2025-06-13 | 10.54 |
| 2025-06-12 | 10.65 |
| 2025-06-11 | 10.59 |
| 2025-06-10 | 10.64 |
| 2025-06-09 | 10.71 |
| 2025-06-06 | 10.88 |
| 2025-06-05 | 10.91 |
| 2025-06-04 | 10.92 |
| 2025-06-03 | 10.91 |
| 2025-06-02 | 10.96 |
| 2025-05-30 | 10.98 |
| 2025-05-29 | 10.91 |
| 2025-05-28 | 10.76 |
| 2025-05-27 | 10.69 |
| 2025-05-23 | 10.52 |
| 2025-05-22 | 10.49 |
| 2025-05-21 | 10.68 |
| 2025-05-20 | 10.92 |
| 2025-05-19 | 10.95 |
| 2025-05-16 | 10.94 |
| 2025-05-15 | 10.79 |
| 2025-05-14 | 10.77 |
| 2025-05-13 | 10.59 |
| 2025-05-12 | 10.50 |
| 2025-05-09 | 10.34 |
| 2025-05-08 | 10.47 |
| 2025-05-07 | 10.53 |
| 2025-05-06 | 10.51 |
| 2025-05-05 | 10.54 |
| 2025-05-02 | 10.61 |
| 2025-05-01 | 10.55 |
| 2025-04-30 | 10.59 |